Approval · Notice of Compliance 25767 · 2021
INPROSUB: Notice of Compliance 25767
Issued April 30, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25767
- Date
- April 30, 2021
- Company
- Ibsa Institut Biochimique SaPazzallo, --, Switzerland
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INPROSUB | 02515504 | Cancelled Pre Market |
Medicinal ingredients
- PROGESTERONE 22.5 MG per ML